| Name | Title | Contact Details |
|---|
KalVista is a clinical stage pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors.
With its acquisition of Spyre Therapeutics, Aeglea is shifting its disease focus to inflammatory bowel disease (IBD). Spyre combines best-in-class antibody engineering, rational therapeutic combinations, and precision immunology approaches to maximize efficacy, safety, and convenience of treatments for IBD.
Pharmathene, Inc is a Annapolis, MD-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Corium International is a Grand Rapids, MI-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
HealthScape is a Tampa, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.